JPRN-UMIN000017650已完成未知
Clinical usefulness of fecal calprotectin for ulcerative colitis - Triple-C study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 879
研究概览
简要总结
In a nationwide study of patients with UC in Japan, we found that the level of FCP and FIT could each identify patients with endoscopic markers of disease severity.The combination of FCP and FIT results can identify patients in remission who are at risk for disease recurrence.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who received total colectomy Patients who received bowel resection within 6 months prior to entry of this study Patients who have recent GI bleeding, infectious colitis or colonic adenocarcinoma. Patients who received leukocyte or granulocyte- monocyte apheresis therapy. Patients who received non-steroid anti-inflammatory agent (NSAID).
研究者
相似试验
已完成
不适用
FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)Crohn's DiseaseUlcerative ColitisInflammatory Bowel DiseaseNCT01676324University of British Columbia289
已完成
不适用
Pro-active Fecal Calprotectin Monitoring PROMOTE-UCUlcerative ColitisNCT03549988University of British Columbia726
终止
不适用
Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuoModerate to Severe Ulcerative ColitisNCT02092389AbbVie10
已完成
不适用
EURECA (EUropeanRElapseCAlprotectin) StudyInflammatory Bowel DiseasesNCT05168917DiaSorin Inc.225
已完成
4 期
Dose Escalation and Remission (DEAR)Ulcerative ColitisNCT00652145James Lewis119